NeurologyLive Friday 5 — June 12, 2020
Take 5 minutes to catch up on NeurologyLive's highlights from the week ending June 12, 2020.
Welcome to NeurologyLive's Friday 5! Every week, the staff compiles 5 highlights of NeurologyLive's widespread coverage in neurology, ranging from newsworthy study findings and FDA action to expert interviews and peer-to-peer panel discussions.
1: AHS 2020: What to Expect From the Annual Scientific Meeting
Ahead of sessions kicking off on June 13, Jessica Ailani, MD, FAHS, offers a look into what data, plenary talks, and developments are set to be presented at the upcoming AHS 2020 annual meeting.
2: Bryan Davis, PsyD, MS: Exploring Masculinity Norms in MS
The clinical healthy psychology fellow at the Mellen Center for MS Treatment and Research at Cleveland Clinic discussed the reasoning behind his study evaluating the conformity of masculine norms in patients with multiple sclerosis.
3: Insights: Educating Patients on Signs of Parkinson Disease OFF Episodes
Peter LeWitt, MD, discusses the optimal ways to communicate with patients and caregivers regarding the identification and management of Parkinson disease OFF episodes.
4: Nusinersen-Treated Patients With SMA Experience Unprecedented Survival
The new data on nusinersen (Spinraza; Biogen) in pre-symptomatic patients from the phase 2 NURTURE study (NCT02386553) are set to be presented at the virtual Cure SMA Research and Clinical Care Meeting.
5: Peer Exchange: MOG-IgG in Multiple Sclerosis
Fred Lublin, MD; Wallace Brownlee, MBChB, PhD, FRACP; Patricia K. Coyle, MD; and Sven Meuth, MD, PhD, discuss the differences between neuromyelitis optica and multiple sclerosis with and without the MOG-IgG antibody.
